SCD and glioblastoma: Therefore, in the present work, aiming at evaluating the therapeutic potential of SCD1 downregulation in GBM, human U87 cells, widely used as a cellular model for GBM studies, were cultured in a medium containing 2% FBS, a serum concentration 5 times lower than that currently supplied to the growth medium classically used to culture these cells [18,28].